Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical company focused on developing new therapeutic approaches for the treatment of cancer and autoimmune diseases. The company specializes in the design and development of protein therapeutics based on protein engineering and structural biology. Their main product is a new class of protein molecules called de novo protein therapeutics, which are designed to target specific molecular targets and immune pathways associated with cancer and autoimmune diseases. Neoleukin Therapeutics, Inc. aims to use advanced protein design technologies to create drugs with higher efficacy and lower side effects than traditional therapies.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
